COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement on the completion of purchase repurchase by the shareholders, repurchase of the equity pledge and re-pledge

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-005

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the completion of purchase repurchase by the shareholders, repurchase of the equity pledge and re-pledge

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

Recently, the company received the notification from the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company):

On January 17, 2013, Kangping Company pledges to the Bank of Jilin Co., Ltd. Changchun Ruixiang Sub-branch (hereinafter referred to as: Ruixiang Sub-branch), the company's unrestricted tradable shares of 53,480,000 shares (accounting for 10.43% of the company's total share capital, accounting for the share of the company On January 17, 2014, the company registered the pledge registration procedure at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch on 21.17%. On the same day, Kangping Company re-plied the above shares to Ruixiang Sub-branch and went through the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on January 17, 2014 and the pledgee went through the pledge registration. The day of the procedure.

On January 23, 2013, Kangping Company pledges to the Bank of Jilin Co., Ltd. Changchun Ruixiang Sub-branch (hereinafter referred to as: Ruixiang Sub-branch), the company's unrestricted tradable shares of 16,430,000 shares (accounting for 3.20% of the company's total share capital, accounting for the shareholding of Kangping Company) On January 21, 2014, the company registered the pledge registration procedure at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. On the same day, Kangping Company re-plied the above shares to Ruixiang Sub-branch and handled the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on January 21, 2014 until the pledgee handled the pledge registration. The day of the procedure.

On July 11, 2013, Kangping Company held 4,420,000 shares of the company's unrestricted shares (0.86% of the company's total share capital, accounting for 1.76% of the company's shares held by Kangping) and Haitong Securities Co., Ltd. Pledged repo transactions; holding 10,250,000 shares of the company's unrestricted shares (accounting for 2% of the company's total share capital, accounting for 4.08% of the company's shares held by Kangping) and Haitong Securities Co., Ltd. On the return-type securities trading, Kangping Company completed the purchase of the above-mentioned shares on January 20, 2014. After the completion of the repurchase, Kangping currently holds a total of 251,475,016 shares of the company, accounting for 49.02% of the company's total share capital.

As of the date of this announcement, Kangping Company holds a total of 251,475,016 shares of the company, and pledges 236,010,000 shares of the company (accounting for 93.85% of the shares held by Kangping), accounting for 46.01% of the company's total. 

 

share capital.

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors